Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials. This collaboration underscores Boehringer Ingelheim's commitment to healthcare innovation and marks the first time that blockchain technology will be explored in a clinical trial setting in Canada. 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Epidemiology, a solution that optimizes the detection of healthcare associated infections (HAIs) in the hospital. Philips IntelliSpace Epidemiology is the only decision-support solution in the U.S. that combines clinical informatics and genomic sequencing information from pathogenic bacteria, aiming to efficiently assist infection control prevention teams in identifying infection transmissions. 
Siemens Healthineers is planning to expand its location in Forchheim in response to the continuing strong demand for medical imaging devices, in particular for CT scanners and x-ray applications. The new "Siemens Healthineers Campus" will consist of an ultra-modern factory for medical components and a new R&D and logistics center alongside the existing facilities. 
Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their pitch deck. 
The Berlin-based start-up Better@Home, founded in the summer of 2018 and operating in Germany, successfully completed its first financing round in December with more than 1 million euros. The investors are CompuGroup Medical Research GmbH, an undisclosed healthcare consultant, and B.I.F. GmbH, the holding company of Hamburg-based business angel Wolfgang Biedermann. 
Veradigm™, an Allscripts (NASDAQ:MDRX), business unit and a leader in providing next-generation healthcare data solutions and systems, is leveraging its capability to communicate directly with a broad network of ambulatory healthcare professionals (HCPs) in order to increase public awareness and access to the Cancer Experience Registry.